RARichard Arbour

Richard Arbour

*This is an algorithmically generated author record based on publicly available information.

Richard Arbour has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Belen Esparis

    1 shared publication
  • Debra L. Wiegand

    1 shared publication
  • Debra L. Wiegand

    University of Maryland School of Nursing, Baltimore, USA

    1 shared publication
  • Elizabeth Leitch

    Elizabeth Leitch is a pain management nurse at Temple University Hospital. She was a member of a team deployed to Sierra Leone in November 2021 to assist local health care providers with management of a burn mass casualty event

    1 shared publication
  • Gideon Agyenim-Boateng

    Gideon Agyenim-Boateng is a staff nurse in the burn intensive care unit at Temple University Hospital, Philadelphia, Pennsylvania. He was a member of a team deployed to Sierra Leone in November 2021 to assist local health care providers with management of a burn mass casualty event

    1 shared publication
  • Hanan M. Alghamdi

    King Fahad Hospital of the University, Imam Abdulrahman Bin Faisal University College of Medicine, Department of Surgery, Saudi Arabia

    1 shared publication

Latest Publications

  • International Burn Disaster Nursing: Care, Commitment, Compassion, and Cost

    by Gideon Agyenim-Boateng, Natalia Ridkodim, Elizabeth Leitch, Kati Hafer, Nina Ng, Richard Arbour

    Background: Burn mass casualty incidents can overwhelm local resources, challenging effective communication, triage, and provision of care. International responders can help by providing education and direct patient care. Local Problem: On November 5, 2021, a fuel tanker truck exploded in Freetown, Sierra Leone, killing or injuring hundreds of people. The needs of the severely burned survivors overwhelmed local resources, requiring an international response. Burn specialist teams from several countries, including the United States, were deployed to provide assistance. Methods: Members of the US burn care team educated local health care practitioners about wound care, physical therapy, and fluid and pain management. Educational content was delivered through lecture and discussion, case studies, clinical application, and bedside teaching. Demonstration of cultural competence and humility, as well as attentiveness to nuances of local communication, helped avoid ethnocentrism and other barriers to collaboration. Public congratulations and formal completion certificates were used to provide meaningful recognition of successful class participation. Results: Before the lecture and discussion intervention, 57 students participating in a pretest assessment had an average score of 53.9% (high, 80%; low, 27.5%). After the intervention, 38 students participating in a posttest assessment had an average score of 79.3% (high, 95%; low, 55%), and local health care providers delivered care with more attention to patient comfort and shared new knowledge with colleagues. Conclusions: Providing optimal burn care and education under austere conditions requires cultural humility and a spirit of inquiry. Attentiveness to communication and cultural nuances promotes collaboration, improves educational effectiveness, and builds local burn care capacity.


  • Self-described Nursing Responses Experienced During Care of Dying Patients and Their Families

    by Richard B. MSN Arbour, Debra L. Wiegand

    Critical care nurses care for dying patients and their families. Little is known about the feelings and experiences of critical care nurses and how they are affected when they provide end-of-life care. Study purpose was to understand lived experiences, responses, and feelings of critical care nurses providing end-of-life care. A descriptive phenomenological design with purposive sampling was used to recruit 19 critical care nurses who cared for dying patients and their families. Interviews were recorded and transcribed verbatim. Nurses were asked open-ended questions about experiences and responses while providing end-of-life care. Coliazzi's method of data analysis was used to inductively determine themes, clusters, and categories. Data saturation was achieved, and methodological rigor was established. Responses included personalizing the experience, sadness, ageism, anger, frustration, relief, and stress. Factors contributing to clinicians' lived experience included previous experiences with death affecting how the experience was personalized among others. Critical care nurses may be unprepared for feelings and responses encountered during end-of-life care. Preparation for feelings and responses encountered during end-of-life care in nursing education and critical care orientation classes is essential. Future research should study optimal mentoring, teaching, and preparation for providing optimal end-of-life care. Study results have implications for practice, education, and research.


  • Nursing Guidelines for Sedation Titration or Pausing to Facilitate Neurological Assessment

    by Richard Arbour

    Q Per The Joint Commission, we need clearer nursing titration/pausing guidelines to facilitate serial neurological assessments. How can we titrate or pause sedation/analgesia infusions to facilitate serial neurological assessments as well as “standard” wake-up assessments in a way that is compliant with regulatory agencies?A Richard Arbour, MSN, RN, CCRN, CNRN, CCNS, CCTC, replies:The Joint Commission (TJC) overview of sedation, analgesia, restraints, and other practices has added additional requirements to documentation, policies, and clinical review as a means to increase standardization of care and, most importantly, patient safety. In particular, TJC has closely evaluated sedation/analgesia dosing and titration.Optimal, goal-directed sedation practices are well established and include 4 components. First, validated clinical assessment tools such as the Sedation-Agitation Scale and the Richmond Agitation-Sedation Scale (RASS) are used to determine therapeutic end points for patients who are not pharmacologically paralyzed.1–3 Second, targeted clinical end points for sedative/hypnotic agents are optimally aimed at “lighter” levels of sedation (eg, a RASS score of 0 to −2 [light sedation]),1 unless higher levels are clinically necessary; patients with these “lighter” levels of sedation are best described as calm and interactive and are able to respond appropriately to stimulation.2,4 Third, sedatives/hypnotic agents should be periodically interrupted or titrated down. This component has become well established since a landmark study in which Kress et al5 identified a connection between daily interruption of sedation and a shorter duration of mechanical ventilation; in current practice, meticulous patient selection and close monitoring are paramount to protect vulnerable patients from harm. Fourth, attention must be given to sedation and analgesic needs and to clinically appropriate nonpharmacological comfort measures, and treatable causes of agitation, pain, and delirium must be addressed.2–4To achieve optimal, goal-directed therapy, all 4 of these points need to be included in a plan of care. Previously, a team may have ordered a “wake-up assessment” for a patient, and that patient’s sedation/analgesic agents may have been abruptly stopped. From a regulatory perspective that assessment order may not have constituted a complete medication order. A complete medication order for titration includes the following items: Note that TJC allows for range orders and multiple range orders, so a provider can order titration increments for a range of times and doses. A direct care nurse would then apply their knowledge and experience with the patient to select the most appropriate interval and dose from among the ordered range when necessary.Clearer titration guidelines to facilitate serial neurological evaluation would include the required order elements and specifically attend to the desired clinical goal for wakefulness or responsiveness (eg, a RASS score of 0 to −1). In addition, downward titration of central nervous system depressants should be specified in institutional policy addressing titration, which should also include a specific callout for daily spontaneous awakening trials (SATs). One such example addressing regulatory considerations is outlined below.To the specific practice question, when considering an awakening trial for neurological assessment followed by specified baseline assessment and goals of care, optimal patient selection from among the neuroscience population is necessary to establish optimal risk/benefit analysis. Documentation should include baseline dosing for any central nervous system depressant, sedation depth, and repeat assessment after each dose change. When a patient’s sedation assessment identifies elements that remain outside the provider-ordered parameters, appropriate communication with the provider and documentation are indicated. If the order does not fit the clinical situation, contact the provider, clarify the order, and document.The importance of interdisciplinary collaboration cannot be overstated: it is essential in optimal patient selection for downward titration of sedation/analgesia to allow neurological evaluation. Respiratory therapy is integral when ventilator support is being titrated as an intervention to manage agitation or ventilator dyssynchrony. In addition to assessing patients and documenting, nurses implement nonpharmacological interventions, calm the patient and family, and facilitate a healing, caring environment. Pharmacy team members offer expertise in optimizing pharmacological therapies for managing pain and agitation. Physicians and advanced care providers are accountable for the overall plan of care and multisystem support. Of particular note is how practices such as sedation/analgesia titration and interruption continue to evolve on the basis of best available evidence and in collaboration with health care regulatory bodies. This collaboration has been useful in practice and in improving patient safety.

  • Open Access

    Brain Death: Assessment, Controversy, and Confounding Factors

    by Richard B. Arbour

    When brain injury is refractory to aggressive management and is considered nonsurvivable, with loss of consciousness and brain stem reflexes, a brain death protocol may be initiated to determine death according to neurological criteria. Clinical evaluation typically entails 2 consecutive formal neurological examinations to document total loss of consciousness and absence of brain stem reflexes and then apnea testing to evaluate carbon dioxide unresponsiveness within the brain stem. Confounding factors such as use of therapeutic hypothermia, high-dose metabolic suppression, and movements associated with complex spinal reflexes, fasciculations, or cardiogenic ventilator autotriggering may delay initiation or completion of brain death protocols. Neurodiagnostic studies such as 4-vessel cerebral angiography can rapidly document absence of blood flow to the brain and decrease intervals between onset of terminal brain stem herniation and formal declaration of death by neurological criteria. Intracranial pathophysiology leading to brain death must be considered along with clinical assessment, patterns of vital signs, and relevant diagnostic studies.


  • Early Metabolic/Cellular-Level Resuscitation Following Terminal Brain Stem Herniation

    by Rn Richard B. Arbour

    Patients with terminal brain stem herniation experience global physiological consequences and represent a challenging population in critical care practice as a result of multiple factors. The first factor is severe depression of consciousness, with resulting compromise in airway stability and lung ventilation. Second, with increasing severity of brain trauma, progressive brain edema, mass effect, herniation syndromes, and subsequent distortion/displacement of the brain stem follow. Third, with progression of intracranial pathophysiology to terminal brain stem herniation, multisystem consequences occur, including dysfunction of the hypothalamic-pituitary axis, depletion of stress hormones, and decreased thyroid hormone bioavailability as well as biphasic cardiovascular state. Cardiovascular dysfunction in phase 1 is a hyperdynamic and hypertensive state characterized by elevated systemic vascular resistance and cardiac contractility. Cardiovascular dysfunction in phase 2 is a hypotensive state characterized by decreased systemic vascular resistance and tissue perfusion. Rapid changes along the continuum of hyperperfusion versus hypoperfusion increase risk of end-organ damage, specifically pulmonary dysfunction from hemodynamic stress and high-flow states as well as ischemic changes consequent to low-flow states. A pronounced inflammatory state occurs, affecting pulmonary function and gas exchange and contributing to hemodynamic instability as a result of additional vasodilatation. Coagulopathy also occurs as a result of consumption of clotting factors as well as dilution of clotting factors and platelets consequent to aggressive crystalloid administration. Each consequence of terminal brain stem injury complicates clinical management within this patient demographic. In general, these multisystem consequences are managed with mechanism-based interventions within the context of caring for the donor’s organs (liver, kidneys, heart, etc.) after death by neurological criteria. These processes begin far earlier in the continuum of injury, at the moment of terminal brain stem herniation. As such, aggressive, mechanism-based care, including hormonal replacement therapy, becomes clinically appropriate before formal brain death declaration to support cardiopulmonary stability following terminal brain stem herniation.


  • Islam, Brain Death, and Transplantation

    by Richard Arbour, Hanan Mesfer Saad AlGhamdi, Linda Peters

    A significant gap exists between availability of organs for transplant and patients with end-stage organ failure for whom organ transplantation is the last treatment option. Reasons for this mismatch include inadequate approach to potential donor families and donor loss as a result of refractory cardiopulmonary instability during and after brainstem herniation. Other reasons include inadequate cultural competence and sensitivity when communicating with potential donor families. Clinicians may not have an understanding of the cultural and religious perspectives of Muslim families of critically ill patients who may be approached about brain death and organ donation. This review analyzes Islamic cultural and religious perspectives on organ donation, transplantation, and brain death, including faith-based directives from Islamic religious authorities, definitions of death in Islam, and communication strategies when discussing brain death and organ donation with Muslim families. Optimal family care and communication are highlighted using case studies and backgrounds illustrating barriers and approaches with Muslim families in the United States and in the Kingdom of Saudi Arabia that can improve cultural competence and family care as well as increase organ availability within the Muslim population and beyond.